Pseudomonas aeruginosa's biofilms and their partners in crime

Data de publicació

2022-05-16T14:38:32Z

2022-05-16T14:38:32Z

2021-08-01

2022-05-16T14:38:32Z

Resum

Pseudomonas aeruginosa biofilms and the capacity of the bacterium to coexist and interact with a broad range of microorganisms have a substantial clinical impact. This review focuses on the main traits of P. aeruginosa biofilms, such as the structural composition and regulatory networks involved, placing particular emphasis on the clinical challenges they represent in terms of antimicrobial susceptibility and biofilm infection clearance. Furthermore, the ability of P. aeruginosa to grow together with other microorganisms is a significant pathogenic attribute with clinical relevance; hence, the main microbial interactions of Pseudomonas are especially highlighted and detailed throughout this review. This article also explores the infections caused by single and polymicrobial biofilms of P. aeruginosa and the current models used to recreate them under laboratory conditions. Finally, the antimicrobial and antibiofilm strategies developed against P. aeruginosa mono and multispecies biofilms are detailed at the end of this review

Tipus de document

Article


Versió publicada

Llengua

Anglès

Publicat per

Elsevier B.V.

Documents relacionats

Reproducció del document publicat a: https://doi.org/10.1016/j.biotechadv.2021.107734

Biotechnology Advances, 2021, vol. 49, p. 107734

https://doi.org/10.1016/j.biotechadv.2021.107734

Citació recomanada

Aquesta citació s'ha generat automàticament.

Drets

cc-by-nc-nd (c) Cendra Gascón, María del Mar et al., 2021

https://creativecommons.org/licenses/by-nc-nd/4.0/

Aquest element apareix en la col·lecció o col·leccions següent(s)